Stocks · Healthcare · Biotechnology
Rani Therapeutics Holdings, Inc. RANI
$0.81 +1.92% Close, Oct 2, 2026 · NASDAQ · Market cap $53.0M
Strong growthExpensive vs sectorHigh risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $4.9M, up 306.4% from a year earlier, accelerating from 164.1% a quarter earlier.
- Operating margin widened to -675.8% from -4106.2% a year earlier.
- The diluted share count rose 412.2% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 5%
- Revenue growth accelerationTop 3%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 18%
- Gross marginTop 11%
- Operating marginBottom 14%
- Accruals (lower is better)Top 20%
- Interest coverBottom 23%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 21%
- Free-cash-flow yieldBottom 13%
- EBITDA / enterprise valueBottom 9%
- Sales / enterprise valueBottom 30%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 26%
- 6-month returnBottom 39%
- 1-year return vs S&P 500Top 24%
- Distance from 52-week highBottom 4%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 18%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 1%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 17%
- Maximum drawdown, 3 yearsBottom 5%
- Beta vs S&P 500 (lower is better)Bottom 9%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 164.1% | 306.4% | ↑ |
| Gross margin | 100.0% | 96.7% | ↓ |
| Operating margin | -4106.3% | -675.8% | ↑ |
| FCF margin | -2604.5% | -417.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 306.4% | 164.1% | ↑ | Top 5% |
| Gross margin | 96.7% | 100.0% | ↓ | Top 11% |
| Operating margin | -675.8% | -4106.3% | ↑ | Bottom 14% |
| Net margin | -618.0% | -2473.8% | ↑ | — |
| Free-cash-flow margin | -417.0% | -2604.5% | ↑ | — |
| Return on invested capital | -64.0% | — | Bottom 18% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -16.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 186.4%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -28.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -138.01%
- Shareholder yield
- -138.01%
- Share count change, 1 year
- +412.2%
- Share count change, 3-year CAGR
- +94.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -28.3%
- Average 2-day reaction, last 8
- -6.8%
- Positive 20 days after report
- 1 of 8
Analysts
- Consensus price target
- $15.67
- Target vs current price
- +1832.7%
- Analysts with a rating
- 7
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | +20.0% | -0.6% | +14.2% | +2.4% | — |
| May 15, 2026 | +33.3% | -2.7% | -3.6% | -31.5% | -29.3% |
| Mar 26, 2026 | -133.3% | -5.3% | -29.4% | -19.7% | -32.2% |
| Nov 6, 2025 | -33.3% | -9.2% | -15.2% | -37.2% | -50.8% |
| Aug 7, 2025 | +5.3% | -3.0% | -3.9% | -16.3% | +163.8% |
| May 13, 2025 | +0.0% | -21.4% | +14.2% | -4.9% | -13.1% |
| Mar 31, 2025 | -12.5% | -7.4% | -11.0% | -19.1% | -62.8% |
| Nov 14, 2024 | -9.1% | -4.9% | -17.0% | -29.6% | -31.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.04 | -$0.05 | +20.0% | $1.7M |
| May 15, 2026 | -$0.04 | -$0.06 | +33.3% | $1.7M |
| Mar 26, 2026 | -$0.07 | -$0.03 | -133.3% | $1.5M |
| Nov 6, 2025 | -$0.12 | -$0.09 | -33.3% | — |
| Aug 7, 2025 | -$0.18 | -$0.19 | +5.3% | — |
| May 13, 2025 | -$0.22 | -$0.22 | +0.0% | $172,000 |
| Mar 31, 2025 | -$0.27 | -$0.24 | -12.5% | $1.0M |
| Nov 14, 2024 | -$0.24 | -$0.22 | -9.1% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 10.59× | — | — | Bottom 30% |
| Free-cash-flow yield | -38.40% | — | — | Bottom 13% |
| Earnings yield | -33.19% | — | — | Bottom 21% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +4.0%
- 200-day average slope (20 days)
- -7.2%
- Distance from 50-day average
- -1.2%
- Distance from 200-day average
- -19.5%
- RSI (14)
- 50.5
- Relative volume
- 0.78×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 80.8%
- Volatility vs own 5-year history
- 29th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.23
- Correlation with S&P 500
- 0.17
- Current drawdown from 1-year high
- -71.6%
- Maximum drawdown, 3 years
- -94.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 18, 2021 | Jul 16, 2025 | -98.8% | 915 days | Not yet recovered |
| Aug 11, 2021 | Aug 16, 2021 | -25.4% | 3 days | 19 days (Sep 13, 2021) |
| Sep 13, 2021 | Oct 6, 2021 | -24.9% | 17 days | 15 days (Oct 27, 2021) |
| Nov 4, 2021 | Nov 8, 2021 | -17.4% | 2 days | 7 days (Nov 17, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $53.0M
- EPS, diluted (TTM)
- -$0.27
- Revenue (TTM)
- $4.9M
- 52-week range
- $0.45 – $3.87
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.7M | $0 | $0 | $1.0M | $1.6M |
| Gross profit | $2.7M | $0 | -$822,000 | $1.0M | $733,000 |
| Operating income | -$51.6M | -$63.5M | -$66.1M | -$53.3M | -$38.3M |
| Net income | -$8.3M | -$30.6M | -$34.0M | -$30.0M | -$29.7M |
| EPS (diluted) | -$0.42 | -$1.28 | -$1.33 | -$1.05 | -$0.45 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1.0M | $172,000 | $0 | $0 | $1.5M | $1.7M | $1.7M |
| Net income | -$6.8M | -$8.9M | -$7.3M | -$6.7M | -$5.4M | -$10.3M | -$7.0M | -$7.4M |
| EPS (diluted) | -$0.24 | -$0.27 | -$0.22 | -$0.18 | -$0.12 | -$0.07 | -$0.04 | -$0.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$32.2M | -$46.5M | -$51.2M | -$35.5M | -$18.7M |
| Capital expenditure | -$506,000 | -$1.6M | -$1.2M | -$268,000 | -$88,000 |
| Free cash flow | -$32.8M | -$48.1M | -$52.5M | -$35.8M | -$18.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $73.6M | $317,000 | $395,000 | $18.6M | $61.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $53.4M
- Total assets
- $60.8M
- Total liabilities
- $12.9M
- Total debt
- $3.5M
- Net debt
- -$1.3M
- Shareholders’ equity
- $39.2M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 7,116,584
- Days to cover
- 14.96
- Change vs previous report
- +11.4%
FINRA short interest, settlement date Sep 15, 2026.